These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2898855)

  • 1. Somatostatin reduces posthypoglycemic insulin resistance in insulin-dependent diabetes mellitus.
    Kollind M; Adamson U; Lins PE
    Acta Endocrinol (Copenh); 1988 Jun; 118(2):173-8. PubMed ID: 2898855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance following nocturnal hypoglycaemia in insulin-dependent diabetes mellitus.
    Kollind M; Adamson U; Lins PE
    Acta Endocrinol (Copenh); 1987 Nov; 116(3):314-20. PubMed ID: 2891235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of insulin resistance following hypoglycemia in insulin-dependent diabetes mellitus.
    Kollind M; Adamson U; Lins PE
    Acta Med Scand; 1988; 223(2):153-7. PubMed ID: 2894750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of growth hormone for blood glucose regulation following insulin-induced nocturnal hypoglycemia in insulin-dependent diabetes mellitus.
    Kollind M; Adamson U; Lins PE; Curstedt T
    Acta Med Scand; 1988; 223(2):159-64. PubMed ID: 2894751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on posthypoglycemic insulin resistance in insulin-dependent diabetes mellitus.
    Kollind M
    Acta Med Scand Suppl; 1988; 727():1-56. PubMed ID: 2903616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus.
    Kinsley BT; Simonson DC
    J Clin Endocrinol Metab; 1996 Feb; 81(2):684-91. PubMed ID: 8636289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the late posthypoglycemic insulin resistance in insulin-dependent diabetes mellitus.
    Fowelin J; Attvall S; von Schenck H; Smith U; Lager I
    Metabolism; 1990 Aug; 39(8):823-6. PubMed ID: 2198433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulus specificity of defects in counterregulatory hormone secretion in insulin-dependent diabetes mellitus: effect of glycemic control.
    Kinsley BT; Widom B; Utzschneider K; Simonson DC
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1383-9. PubMed ID: 7962332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.
    Popp DA; Shah SD; Cryer PE
    J Clin Invest; 1982 Feb; 69(2):315-26. PubMed ID: 6120181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glycemic control on glucose counterregulation during hypoglycemia in NIDDM.
    Levy CJ; Kinsley BT; Bajaj M; Simonson DC
    Diabetes Care; 1998 Aug; 21(8):1330-8. PubMed ID: 9702443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetogenic action of GH and cortisol in insulin-dependent diabetes mellitus. Aspects of the mechanisms behind the Somogyi phenomenon.
    Kollind M; Adamson U; Lins PE; Efendic S
    Horm Metab Res; 1987 Apr; 19(4):156-9. PubMed ID: 2884179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further defects in counterregulatory responses induced by recurrent hypoglycemia in IDDM.
    Davis MR; Mellman M; Shamoon H
    Diabetes; 1992 Oct; 41(10):1335-40. PubMed ID: 1397708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired glucose disposal following mild hypoglycemia in nondiabetic and type I diabetic humans.
    Davis MR; Shamoon H
    Metabolism; 1992 Feb; 41(2):216-23. PubMed ID: 1736045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opiate blockade enhances hypoglycemic counterregulation in normal and insulin-dependent diabetic subjects.
    Caprio S; Gerety G; Tamborlane WV; Jones T; Diamond M; Jacob R; Sherwin RS
    Am J Physiol; 1991 Jun; 260(6 Pt 1):E852-8. PubMed ID: 2058661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of counterregulatory hormone secretion and symptoms during hypoglycemia in IDDM. Effect of glycemic control.
    Kinsley BT; Widom B; Simonson DC
    Diabetes Care; 1995 Jan; 18(1):17-26. PubMed ID: 7698043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive insulin therapy reduces counterregulatory hormone responses to hypoglycemia in patients with type I diabetes.
    Simonson DC; Tamborlane WV; DeFronzo RA; Sherwin RS
    Ann Intern Med; 1985 Aug; 103(2):184-90. PubMed ID: 3893253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient insulin resistance following infusion of adrenaline in type 1 (insulin-dependent) diabetes mellitus.
    Kollind M; Adamson U; Lins PE; Hamberger B
    Diabetologia; 1988 Aug; 31(8):603-6. PubMed ID: 2906021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans.
    Gosmanov NR; Szoke E; Israelian Z; Smith T; Cryer PE; Gerich JE; Meyer C
    Diabetes Care; 2005 May; 28(5):1124-31. PubMed ID: 15855577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.